Lack of association between p.Ser167Asn variant of Parkin and Parkinson's disease: A meta-analysis of 15 studies involving 2,280 cases and 2,459 controls

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 1, 2012, Pages 38-47

  Zhang, Yi ^a   Wang, Zhen Zhen ^b   Sun, Hong Mei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Association analysis; Meta analysis; P.Ser167Asn variant; Parkin; Parkinson's disease

Indexed keywords

ASPARAGINE; PARKIN; SERINE;

ARTICLE; CONFIDENCE INTERVAL; ENZYME POLYMORPHISM; ETHNICITY; GENETIC MODEL; HUMAN; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN VARIANT; RISK; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MODELS, GENETIC; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; UBIQUITIN-PROTEIN LIGASES;

EID: 83755163050     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31250     Document Type: Article

References (56)

1. Aguiar PC, Lessa PS, Godeiro CJ, Barsottini O, Felicio AC, Borges V, Silva SM, Saba RA, Ferraz HB, Moreira-Filho CA, et al. 2008. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients. Mov Disord 23: 1228-1233.
2. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
3. Biswas A, Maulik M, Das SK, Ray K, Ray J. 2007. Parkin polymorphisms: Risk for Parkinson's disease in Indian population. Clin Genet 72: 484-486.
4. Brooks J, Ding J, Simon-Sanchez J, Paisan-Ruiz C, Singleton AB, Scholz SW. 2009. Parkin and PINK1 mutations in early-onset Parkinson's disease: Comprehensive screening in publicly available cases and control. J Med Genet 46: 375-381.
5. Chang XL, Mao XY, Li HH, Zhang JH, Li NN, Burgunder JM, Peng R, Tan EK. 2011. Association of GWAS loci with PD in China. Am J Med Genet Part B 156B: 334-339.
6. Chien HF, Rohe CF, Costa MD, Breedveld GJ, Oostra BA, Barbosa ER, Bonifati V. 2006. Early-onset Parkinson's disease caused by a novel Parkin mutation in a genetic isolate from north-eastern Brazil. Neurogenetics 7: 13-19.
7. Colhoun HM, McKeigue PM, Davey SG. 2003. Problems of reporting genetic associations with complex outcomes. Lancet 361: 865-872.
8. de Lau LM, Breteler MM. 2006. Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535.
9. den Dunnen JT, Antonarakis SE. 2001. Nomenclature for the description of human sequence variations. Hum Genet 109: 121-124.
10. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
11. Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S, Hering R, Riess O, Romac S, Klein C, et al. 2004. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23: 525.
12. Dodson MW, Guo M. 2007. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 17: 331-337.
13. Eerola J, Launes J, Hellstrom O, Tienari PJ. 2002. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland. Neurosci Lett 330: 296-298.
14. Egger M, Davey SG, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
15. Evangelou E, Maraganore DM, Ioannidis JP. 2007. Meta-analysis in genome-wide association datasets: Strategies and application in Parkinson disease. PLoS ONE 2: e196.
16. Evangelou E, Maraganore DM, Annesi G, Brighina L, Brice A, Elbaz A, Ferrarese C, Hadjigeorgiou GM, Krueger R, Lambert JC, et al. 2010. Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: Large-scale collaborative study. Am J Med Genet Part B 153B: 220-228.
17. Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Marder K, Conneally PM, Nichols WC. 2003. Heterozygosity for a mutation in the Parkin gene leads to later onset Parkinson disease. Neurology 60: 796-801.
18. Gandhi S, Wood NW. 2005. Molecular pathogenesis of Parkinson's disease. Hum Mol Genet 14: 2749-2755.
19. Greenamyre JT, Hastings TG. 2004. Parkinson's-divergent causes, convergent mechanisms. Science 304: 1120-1122.
20. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. 2003. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila Parkin mutants. Proc Natl Acad Sci USA 100: 4078-4083.
21. Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-Santana H, Vieregge P, Jacobs H, Bressman SB, et al. 2004. Distribution, type, and origin of Parkin mutations: Review and case studies. Mov Disord 19: 1146-1157.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
23. Hong Y, Zhang SB. 2006. Relationship between genetic polymorphism of Parkin gene and genetic susceptibility to Parkinson's disease. Chin J Contemp Neurol Neurosurg 6: 291-294.
24. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, et al. 2005. A network of investigator networks in human genome epidemiology. Am J Epidemiol 162: 302-304.
25. Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, et al. 2007. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 61: 47-54.
26. Khan NL, Scherfler C, Graham E, Bhatia KP, Quinn N, Lees AJ, Brooks DJ, Wood NW, Piccini P. 2005. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single Parkin mutation. Neurology 64: 134-136.
27. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. 1998. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
28. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. 2007. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6: 652-662.
29. Koziorowski D, Hoffman-Zacharska D, Slawek J, Szirkowiec W, Janik P, Bal J, Friedman A. 2010. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease. Parkinsonism Relat Disord 16: 136-138.
30. Lesage S, Lohmann E, Tison F, Durif F, Durr A, Brice A. 2008. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet 45: 43-46.
31. Lincoln SJ, Maraganore DM, Lesnick TG, Bounds R, de Andrade M, Bower JH, Hardy JA, Farrer MJ. 2003. Parkin variants in North American Parkinson's disease: Cases and controls. Mov Disord 18: 1306-1311.
32. Lohmann E, Thobois S, Lesage S, Broussolle E, du Montcel ST, Ribeiro MJ, Remy P, Pelissolo A, Dubois B, Mallet L. et al. 2009. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology 72: 110-116.
33. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.
34. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, et al. 2000. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 342: 1560-1567.
35. Lucking CB, Chesneau V, Lohmann E, Verpillat P, Dulac C, Bonnet AM, Gasparini F, Agid Y, Durr A, Brice A. 2003. Coding polymorphisms in the Parkin gene and susceptibility to Parkinson disease. Arch Neurol 60: 1253-1256.
36. Martinez HR, Gonzalez-Gonzalez H, Cantu-Martinez L, Rangel-Guerra R, Hernandez-Castillo CD, Vergara-Saavedra JJ, Ramos-Gonzalez MR, Cerda-Flores RM, Morales-Garza MA, Guerrero-Munoz MJ, et al. 2010. PARKIN-coding polymorphisms are not associated with Parkinson's disease in a population from northeastern Mexico. Neurosci Lett 468: 264-266.
37. Mata IF, Alvarez V, Garcia-Moreira V, Guisasola LM, Ribacoba R, Salvador C, Blazquez M, Sarmiento RG, Lahoz CH, Menes BB, et al. 2002. Single-nucleotide polymorphisms in the promoter region of the PARKIN gene and Parkinson's disease. Neurosci Lett 329: 149-152.
38. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. 1999. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354: 1896-1900.
39. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, et al. 2011. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: A meta-analysis of genome-wide association studies. Lancet 377: 641-649.
40. Ning YP, Liu ZS, Li BQ, Xu YM. 2003. The study of relationship between polymorphism in Parkin gene and sporadic Parkinson's disease. J Clin Neurol 16: 129-130.
41. Okubadejo N, Britton A, Crews C, Akinyemi R, Hardy J, Singleton A, Bras J. 2008. Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS ONE 3: e3421.
42. Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, et al. 2003. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol 53: 624-629.
43. Oliveri RL, Zappia M, Annesi G, Bosco D, Annesi F, Spadafora P, Pasqua AA, Tomaino C, Nicoletti G, Pirritano D, et al. 2001. The Parkin gene is not involved in late-onset Parkinson's disease. Neurology 57: 359-362.
44. Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC. 2009. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology 73: 279-286.
45. Peng R, Gou Y, Yuan Q, Li T, Latsoudis H, Yuan G, Luo D, Liu X, Collier DA. 2003. Mutation screening and association analysis of the Parkin gene in Parkinson's disease patients from South-West China. Eur Neurol 49: 85-89.
46. Poorkaj P, Nutt JG, James D, Gancher S, Bird TD, Steinbart E, Schellenberg GD, Payami H. 2004. Parkin mutation analysis in clinic patients with early-onset Parkinson's disease. Am J Med Genet Part A 129A: 44-50.
47. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, et al. 2009. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307.
48. Satoh J, Kuroda Y. 1999. Association of codon 167 Ser/Asn heterozygosity in the Parkin gene with sporadic Parkinson's disease. Neuroreport 10: 2735-2739.
49. Schrag A, Schott JM. 2006. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 5: 355-363.
50. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, et al. 2009. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312.
51. Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, et al. 2006. Influence of heterozygosity for Parkin mutation on onset age in familial Parkinson disease: The GenePD study. Arch Neurol 63: 826-832.
52. Wang M, Hattori N, Matsumine H, Kobayashi T, Yoshino H, Morioka A, Kitada T, Asakawa S, Minoshima S, Shimizu N, et al. 1999. Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann Neurol 45: 655-658.
53. Wang T, Liang ZH, Hou XM, Sun SG, Tong ET. 2003. Polymorphism of Parkin in Parkinson's disease. Stroke Nervous Dis 10: 87-89.
54. West A, Periquet M, Lincoln S, Lucking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, et al. 2002. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet 114: 584-591.
55. Wu YR, Wu CH, Chao CY, Kuan CC, Zhang WL, Wang CK, Chang CY, Chang YC, Lee-Chen GJ, Chen CM. 2010. Genetic analysis of Parkin in early onset Parkinson's disease (PD): Novel intron 9g>a single nucleotide polymorphism and risk of Taiwanese PD. Am J Med Genet Part B 153B: 229-234.
56. Zhao XP, Xie HJ, Tang GM, Zhao WW, Xu L, Su JJ, Hao YX, Ren DM. 2003. The relationship between parkin gene polymorphism and Parkinson's disease. Chin J Neurol 36: 87-89.